← Xtant Medical Holdings, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($19.5m) |
($52.4m)
-168.86%
|
($70.1m)
-33.75%
|
($8.2m)
+88.27%
|
($7.0m)
+14.57%
|
($4.8m)
+30.96%
|
($8.5m)
-74.98%
|
$660k
+107.78%
|
($16.4m)
-2592.27%
|
$5.0m
+130.23%
|
— | |
| Depreciation, Depletion and Amortization | $7.2m | $8.4m | $6.6m | $3.1m | $2.1m | $1.3m | $1.3m | $3.2m | $4.2m | $5.2m | $4.7m | |
| Depreciation | $2.8m | $3.8m | $3.2m | $3.1m | $2.0m | $1.3m | $1.2m | $1.8m | $2.5m | $3.6m | $4.7m | |
| Amortization of Intangible Assets | $4.5m | $4.6m | $2.5m | $58k | $100k | $100k | $100k | $1.4m | $1.7m | $1.6m | — | |
| Depreciation Expense | $7.2m | $8.4m | $6.6m | $3.1m | $2.1m | $1.3m | $1.3m | $3.2m | $4.2m | $5.2m | $4.7m | |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | — | — | — | — | — | ($1.9m) | $21k | ($38k) | $21k | |
| Share-based Payment Arrangement, Noncash Expense | $523k | $212k | $694k | $515k | $1.1m | $2.2m | $2.5m | $2.7m | $4.1m | $2.9m | $2.9m | |
| Share-based Payment Arrangement, Expense | $488k | $212k | — | — | — | — | — | — | — | — | $2.9m | |
| Stock-based compensation | $523k | $212k | $694k | $515k | $1.1m | $2.2m | $2.5m | $2.7m | $4.1m | $2.9m | $2.9m | |
| Goodwill, Impairment Loss | — | — | $38.3m | — | — | — | — | — | — | — | $0 | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $0 | — | — | — | — | — | — | — | — | — | — | |
| Nonoperating Income (Expense) | ($11.9m) | ($14.6m) | ($10.0m) | ($5.9m) | ($6.0m) | ($995k) | ($1.7m) | $9.1m | ($4.2m) | ($283k) | — | |
| Other Nonoperating Income (Expense) | ($352k) | ($75k) | $3k | ($101k) | — | — | — | — | ($33k) | $73k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $2.7m | ($4.7m) | ($2.5m) | $647k | ($2.9m) | $319k | $3.9m | $8.7m | $755k | $591k | $3.0m | |
| Provision for reserve on accounts receivable | — | — | — | — | — | — | $243k | $497k | $823k | $1.4m | — | |
| Trade accounts receivable | ($2.7m) | $4.7m | $2.5m | ($647k) | $2.9m | ($319k) | ($3.9m) | ($8.7m) | ($755k) | ($591k) | — | |
| Increase (Decrease) in Inventories | $4.1m | ($2.1m) | ($40k) | ($692k) | $5.8m | ($2.6m) | $1.2m | $1.9m | $2.5m | $2.0m | ($3.1m) | |
| Inventory Write-down | — | — | — | — | — | — | $1.8m | $357k | $485k | $3.7m | — | |
| Inventories | ($4.1m) | $2.1m | $40k | $692k | ($5.8m) | $2.6m | ($1.2m) | ($1.9m) | ($2.5m) | ($2.0m) | ($3.1m) | |
| Increase (Decrease) in Accounts Payable | $319k | ($1.6m) | ($3.0m) | ($4.3m) | $101k | ($332k) | $875k | $3.0m | $1.0m | ($3.1m) | ($586k) | |
| Accrued liabilities | ($2.1m) | ($1.5m) | $311k | $1.5m | ($512k) | ($1.1m) | $1.1m | $3.8m | ($2.9m) | $4.2m | ($692k) | |
| Other | — | — | — | — | — | — | — | $16k | ($26k) | ($76k) | — | |
| Prepaid and other assets | ($484k) | ($460k) | $1.1m | $204k | $40k | ($67k) | $261k | $220k | ($218k) | ($1.5m) | — | |
| Net Cash Provided by (Used in) Operating Activities | ($14.4m) |
($543k)
+96.23%
|
$1.2m
+323.13%
|
($413k)
-134.08%
|
($731k)
-77.00%
|
$439k
+160.05%
|
($5.3m)
-1316.63%
|
($9.5m)
-78.15%
|
($11.9m)
-25.02%
|
$12.5m
+205.46%
|
$9.2m
-27.04%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($5.8m) | ($1.6m) | $624k | $879k | $1.5m | $2.1m | $1.8m | $1.5m | $4.1m | $2.4m | ($1.4m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | ($21.2m) | ($48.2m) | $61k | — | — | — | — | — | — | ($3.0m) | |
| Payments to Acquire Investments | — | — | — | — | — | — | — | $17.0m | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | — | $4.5m | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($5.8m) | ($1.6m) | ($367k) | ($544k) | ($1.3m) | ($1.9m) | ($1.6m) | ($24.8m) | ($3.7m) | $7.9m | $19.3m | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $0 | — | — | — | $315k | $411k | — | — | — | $8.0m | ($10.9m) | |
| Gain (Loss) on Extinguishment of Debt | $0 | — | — | ($1.5m) | ($3.5m) | — | — | — | — | — | — | |
| Proceeds from Issuance of Long-term Debt | — | $12.8m | — | — | — | — | — | $4.8m | $5.0m | — | $0 | |
| Payments on long-term debt | $0 | — | — | — | ($315k) | ($411k) | — | — | — | ($8.0m) | — | |
| Proceeds from Debt Issuance | — | $12.8m | — | — | — | — | — | $4.8m | $5.0m | — | — | |
| Debt issuance costs | — | — | — | — | — | — | — | ($239k) | ($651k) | ($49k) | — | |
| Proceeds from Issuance of Common Stock | $0 | — | — | — | $620k | $18.4m | $9.3m | $14.0m | $13k | — | $0 | |
| Payment of taxes from withholding of common stock upon vesting and settlement of restricted stock units | — | — | — | — | — | ($201k) | — | ($261k) | ($178k) | ($126k) | — | |
| Net Cash from Financing Activities | $10.3m |
($10.4m)
-201.90%
|
$6.8m
+165.18%
|
($148k)
-102.17%
|
— | $36.4m |
$54.2m
+49.14%
|
$78.2m
+44.24%
|
$112.6m
+44.01%
|
($65k)
-100.06%
|
— | |
| Net cash (used in) provided by financing activities | $16.4m |
$2.4m
-85.22%
|
$3.1m
+27.46%
|
($603k)
-119.48%
|
($861k)
-42.79%
|
$17.5m
+2132.17%
|
$9.0m
-48.45%
|
$19.7m
+118.30%
|
$16.1m
-18.37%
|
($9.6m)
-159.54%
|
— | |
| Net Cash Provided by (Used in) Financing Activities | $16.4m |
$2.4m
-85.22%
|
$3.1m
+27.46%
|
($603k)
-119.48%
|
($861k)
-42.79%
|
$17.5m
+2132.17%
|
$9.0m
-48.45%
|
$19.7m
+118.30%
|
$16.1m
-18.37%
|
($9.6m)
-159.54%
|
($21.9m)
-129.11%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | ($1.6m) | ($2.9m) | $16.0m | $2.1m | ($14.6m) | $298k | $11.1m | $11.9m | |
| Cash and cash equivalents and restricted cash at beginning of year | — | — | $6.8m | $5.2m | $2.3m | $18.4m | $20.5m | $5.9m | $6.2m | $17.3m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $3.9m | ($1.6m) | ($2.9m) | $18.4m | $20.5m | $5.9m | $6.2m | $17.3m | $11.9m | |
| Net change in cash and cash equivalents and restricted cash | — | — | $3.9m | ($1.6m) | ($2.9m) | $16.0m | $2.1m | ($14.6m) | $298k | $11.1m | — | |
| Restricted cash | — | — | — | — | — | $144k | $209k | $208k | $22k | $275k | — | |
| Total cash and cash equivalents and restricted cash reported in the consolidated balance sheets | — | — | — | — | $2.3m | $18.4m | $20.5m | $5.9m | $6.2m | $17.3m | — | |
| Effect of Exchange Rate on Cash | — | — | — | — | — | — | — | $24k | ($149k) | $232k | $232k | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $0 | — | — | — | — | — | — | — | $13k | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $627k | $186k | $51k | $13k | $846k | $1.5m | $2.6m | $3.6m | $3.1m | — | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | $121k | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | $717k | $203k | $121k | $3k | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | — | — | — | — | — | $265k | $5k | ($60k) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $717k | $203k | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | ($25k) | ($10k) | $103k | ($61k) | $369k | $86k | $93k | $115k | $264k | ($251k) | — | |
| General and Administrative Expense | $15.8m | $15.2m | $12.9m | $17.9m | $13.5m | $14.4m | $15.5m | $25.9m | $28.7m | $29.4m | — | |
| Goodwill | $41.5m | $41.5m | $3.2m | $3.2m | $3.2m | $3.2m | $3.2m | $7.3m | $7.3m | $6.1m | $0 | |
| Income Tax Expense (Benefit) | $50k | $0 | — | ($98k) | $296k | — | $69k | ($1.7m) | $187k | $2.0m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $4.2m | $3.7m | — | |
| Investment Income, Interest | — | — | — | — | — | — | $31k | $149k | — | $94k | — | |
| Operating Expenses | $69.8m | $87.9m | $103.6m | $44.8m | $35.1m | $36.3m | $38.9m | $65.6m | $80.3m | $77.0m | — | |
| Operating Lease, Expense | — | — | — | $588k | $600k | $600k | $600k | $700k | $900k | $1.2m | — | |
| Payments of Financing Costs | — | — | — | — | — | $136k | — | — | — | — | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $71.8m | $64.5m | — | — | — | — | — | — | — | |
| Stock or Unit Option Plan Expense | — | $127k | — | — | — | — | — | — | — | — | — | |
| Non-cash interest | $6.8m | $14.7m | $9.8m | $5.7m | $6.0m | $147k | $233k | $386k | $522k | $537k | — | |
| Loss (gain) on sale of fixed assets | $25k | $10k | $103k | ($61k) | ($369k) | ($86k) | ($93k) | ($115k) | ($264k) | $251k | — | |
| Restructuring Expense | — | — | — | — | — | $839k | $1.8m | $357k | $485k | $3.7m | — | |
| Proceeds from Sale of PP&E | $16k | $33k | $257k | $335k | $241k | $225k | $205k | $175k | $383k | $232k | — | |
| Repayments on line of credit | — | — | — | — | — | ($36.5m) | ($54.5m) | ($77.0m) | ($105.1m) | ($101.3m) | — | |
| Payments on financing leases | — | — | — | ($455k) | ($156k) | ($50k) | ($50k) | ($63k) | ($65k) | ($67k) | — | |
| Proceeds from Stock Issuance | $0 | — | — | — | — | — | — | — | $13k | — | — | |
| Cash and cash equivalents | $2.6m | $2.9m | $6.8m | — | $2.3m | $18.2m | $20.3m | $5.7m | $6.2m | $17.1m | $5.4m |